A community-based evaluation of the effect of renal transplantation on survival in patients with renal-replacement therapy

Japanese Journal of Nephrology

Volumn 38, Issue 10, 1996, Pages 449-454

  Shiohira, Yoshiki ^a   Iseki, Kunitoshi ^b   Kowatari, Teruo ^c   Uehara, Hajime ^a   Yoshihara, Kunio ^d   Nishime, Keizo ^e   Arakaki, Yoshitaka ^a   Koyama, Yuzo ^f   Ogawa, Yoshihide ^f   Fukiyama, Koshiro ^f  

^a Okinawa Prefectural Chubu Hospital   (Japan)

^b UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

^c Makiminato Chuo Hospital   (Japan)

^d National Okinawa Hospital   (Japan)

^e Okinawa Kyodo Hospital   (Japan)

^f UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Hemodialysis; Renal transplantation; Survival

Indexed keywords

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; DONOR; FEMALE; FOLLOW UP; HUMAN; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; RENAL REPLACEMENT THERAPY; SURVIVAL RATE;

ADULT; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; SURVIVAL RATE; TISSUE DONORS;

EID: 0030255065     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Kjellstrand CM, Hylander B, Collins J: Mortality on dialysis-On the influence of early start, patients characteristics, and transplantation and acceptance rates. Am J Kidney Dis 15: 483-490, 1990
2. Iseki K, Kawazoe N, Osawa A, Fukiyama K: Survival analysis of dialysis patients in Okinawa, Japan (1971-1990). Kidney Int 43: 404-409, 1993
3. Iseki K, Kawazoe N, Fukiyama K: Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 44: 115-119, 1993
4. Degoulet P, Legrain M, Reach I et al: Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron 31: 103-110, 1982
5. Lowrie EG, Lew NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15: 458-482, 1990
6. Hutchinson TA, Thomas DC, Lemieux JC, Harvey CE: Prognostically controlled comparison of dialysis and renal transplantation. Kidney Int 26: 44-51, 1984
7. Vollmer WM, Wahl PW, Blagg CR: Survival with dialysis and transplantation in patients with end stage renal disease. N Engl J Med 308: 1553-1558, 1983
8. Krakauer H, Grauman JS, McMullan MR, Creede CC: The recent U.S. experience in the treatment of end-stage renal disease by dialysis and transplantation. N Engl J Med 308: 1558-1563, 1983
9. Bradley JR, Evans DB, Calne RY: Long-term survival in haemodialysis patients. Lancet i: 295-296, 1987
10. Maher ER, Curtis JR. Mortality and morbidity of long-term haemodialysis. Lancet i: 452-453, 1987
11. Iseki K, Nishime K, Uehara H et al: Effect of renal diseases and comorbid conditions on survival in chronic dialysis patients. Nephron 68: 80-86, 1994
12. Maeda K, Iida Y, Otsuji Y et al: Profile of chronic dialysis patients in Japan in 1990. Jpn J Dial 25: 1-42, 1992 (in Japanese)
13. Cameron JS: The future of nephrology with special regard to advances in treatment. Kidney Int 42: S203-S214, 1992
14. Brenner BM, Cohen RA, Milford EL: In renal transplantation, one size may not fit all. J Am Soc Nephrol 3: 162-169, 1992
15. Gutman RA, Stead WW, Robinson RR: Physical activity and employment status of patients on maintenance dialysis. N Engl J Med 304: 309-313, 1981
16. Evans RW, Manninen DL, Garnson LP et al: The quality of life of patients with end-stage renal disease N Engl J Med 312: 553-559, 1985
17. Eschbach JW, Abdulhadi MH, Browne JK et al: Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. Ann Intern Med 111: 992-1000, 1989
18. Iseki K, Nishime K, Uehara H et al: Increased risk of cardiovascular disease with erythropoietin in chronic dialysis patients. Nephron 72: 30-36, 1996
19. Kleimnan KS, Coburn JW: Editorial review. Amyloid syndromes associated with hemodialysis. Kidney Int 35: 567-575, 1989
20. Iseki K, Osawa A, Fukiyama K: Evidence for increased cancer deaths in chronic dialysis patients. Am J Kidney Dis 22: 308-313, 1993
21. Penn I: Cancer as a complication of clinical transplantation. Transplant Proc 9: 1121-1127, 1977
22. London NJ, Farmery SM Will EJ et al: Risk of neoplasia in renal transplant patients. Lancet 346: 403-406, 1995
23. Rubin RH, Wolfson JS, Cosimi AB, Tolkoff-Rubin NE: Infection in the renal transplant recipient. Am J Med 70: 405-411, 1981
24. Tilney NL, Strom TB, Vineyard GC, Merrill JP: Factors contributing to the declining mortality rate in renal transplantation. N Engl J Med 299: 1321-1325, 1978
25. Burt RK, Gupta-Burt S, Suki WN et al: Reversal of left ventricular dysfunction after renal transplantation. Ann Int Med 111: 635-640, 1989
26. Harnett JD, Foley RN, Kent GM et al: Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors. Kidney Int 47: 884-890, 1995